Wayfinding Financial’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$360K Buy
1,024
+74
+8% +$26.4K 0.16% 92
2025
Q4
$310K Buy
950
+71
+8% +$22.5K 0.13% 105
2025
Q3
$248K Buy
879
+7
+0.8% +$2.03K 0.11% 121
2025
Q2
$263K Buy
872
+167
+24% +$47.3K 0.12% 115
2025
Q1
$219K Buy
+705
New +$208K 0.1% 132
2024
Q3
Sell
-732
Closed -$228K 44
2024
Q2
$228K Sell
732
-9
-1% -$2.64K 0.13% 109
2024
Q1
$227K Buy
741
+2
+0.3% +$585 0.13% 106
2023
Q4
$213K Buy
+739
New +$201K 0.15% 103
2023
Q1
Sell
-927
Closed -$207K 107
2022
Q4
$207K Buy
+927
New +$248K 0.17% 85
2022
Q3
Sell
-1,010
Closed -$245K 82
2022
Q2
$245K Buy
1,010
+3
+0.3% +$735 0.22% 69
2022
Q1
$238K Buy
1,007
+80
+9% +$18.4K 0.2% 73
2021
Q4
$207K Buy
+927
New +$196K 0.17% 85

Other funds holding AMGN

Wayfinding Financial's AMGN Position: Q1 2026 in Review

Wayfinding Financial increased its Amgen (AMGN) stake by 7.8% in Q1 2026, buying an estimated $26.4K and bringing the position to 1,024 shares worth $360K. The position accounts for 0.16% of the portfolio, ranked #92.

Wayfinding Financial first reported a position in AMGN in Q4 2021 and has held it in 12 quarters since. 3,126 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Wayfinding Financial held 1,024 shares of Amgen worth $360K as of Q1 2026.
  • Wayfinding Financial bought 74 Amgen shares in Q1 2026, an estimated $26.4K.
  • Amgen made up 0.16% of Wayfinding Financial's portfolio in Q1 2026, its #92 holding.
  • Wayfinding Financial first reported a position in Amgen in Q4 2021 and has held it in 12 quarters since.
  • 3,126 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Wayfinding Financial's 13F filing for Q1 2026, filed 12 May 2026.